GR1002049B - Isolation and characterization of genes resistant to anthracycline antibiotics - Google Patents

Isolation and characterization of genes resistant to anthracycline antibiotics

Info

Publication number
GR1002049B
GR1002049B GR890100339A GR890100339A GR1002049B GR 1002049 B GR1002049 B GR 1002049B GR 890100339 A GR890100339 A GR 890100339A GR 890100339 A GR890100339 A GR 890100339A GR 1002049 B GR1002049 B GR 1002049B
Authority
GR
Greece
Prior art keywords
characterization
isolation
anthracycline antibiotics
genes resistant
host
Prior art date
Application number
GR890100339A
Other languages
English (en)
Other versions
GR890100339A (el
Inventor
Marinella Caruso
Anna Luisa Colombo
Luisa Garofano
Francesca Torti
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of GR890100339A publication Critical patent/GR890100339A/el
Publication of GR1002049B publication Critical patent/GR1002049B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/56Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR890100339A 1988-05-27 1989-05-23 Isolation and characterization of genes resistant to anthracycline antibiotics GR1002049B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888812697A GB8812697D0 (en) 1988-05-27 1988-05-27 Isolation & characterisation of genes resistant to anthracycline antibiotics

Publications (2)

Publication Number Publication Date
GR890100339A GR890100339A (el) 1990-03-12
GR1002049B true GR1002049B (en) 1995-11-16

Family

ID=10637720

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100339A GR1002049B (en) 1988-05-27 1989-05-23 Isolation and characterization of genes resistant to anthracycline antibiotics

Country Status (19)

Country Link
EP (1) EP0371112B1 (el)
JP (1) JP3240052B2 (el)
KR (1) KR970010761B1 (el)
AT (1) ATE115627T1 (el)
AU (1) AU610411B2 (el)
CA (1) CA1335575C (el)
DE (1) DE68920007T2 (el)
DK (1) DK175446B1 (el)
FI (1) FI97728C (el)
GB (1) GB8812697D0 (el)
GR (1) GR1002049B (el)
HU (2) HU217210B (el)
IE (1) IE66718B1 (el)
IL (1) IL90386A (el)
NZ (1) NZ229237A (el)
PT (1) PT90667B (el)
RU (1) RU2118367C1 (el)
WO (1) WO1989011532A1 (el)
ZA (1) ZA893979B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN799596A0 (en) * 1996-02-09 1996-03-07 Northern Sydney Area Health Service Chemotherapy resistance gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
JPS6158589A (ja) * 1984-08-30 1986-03-25 Meiji Seika Kaisha Ltd ビアラホス生産遺伝子及び耐性遺伝子
US4935340A (en) * 1985-06-07 1990-06-19 Eli Lilly And Company Method of isolating antibiotic biosynthetic genes

Also Published As

Publication number Publication date
PT90667A (pt) 1989-11-30
WO1989011532A1 (en) 1989-11-30
DK21890A (da) 1990-01-26
DK175446B1 (da) 2004-10-25
DE68920007T2 (de) 1995-04-27
AU610411B2 (en) 1991-05-16
NZ229237A (en) 1992-05-26
EP0371112B1 (en) 1994-12-14
DE68920007D1 (de) 1995-01-26
FI97728B (fi) 1996-10-31
ZA893979B (en) 1990-02-28
EP0371112A1 (en) 1990-06-06
IE66718B1 (en) 1996-01-24
JPH02504470A (ja) 1990-12-20
PT90667B (pt) 1994-10-31
AU3692789A (en) 1989-12-12
HU893264D0 (en) 1990-07-28
KR900702024A (ko) 1990-12-05
GB8812697D0 (en) 1988-06-29
IE891730L (en) 1989-11-27
IL90386A0 (en) 1989-12-15
HUT52818A (en) 1990-08-28
FI900359A0 (fi) 1990-01-24
DK21890D0 (da) 1990-01-26
FI97728C (fi) 1997-02-10
ATE115627T1 (de) 1994-12-15
HU217210B (hu) 1999-12-28
RU2118367C1 (ru) 1998-08-27
CA1335575C (en) 1995-05-16
IL90386A (en) 1995-12-31
GR890100339A (el) 1990-03-12
KR970010761B1 (ko) 1997-06-30
JP3240052B2 (ja) 2001-12-17

Similar Documents

Publication Publication Date Title
CA2085134A1 (en) Gdf-1
IL109774A0 (en) Recombinant dna, vectors and host organisms containing them, and transgenic plants containing the recombinant dna
GB2317875A (en) Computer printable dual No 10 envelope assembly
MX9801864A (es) Materiales y metodos con relacion a la union y presentacion de substancias sobre superficies de celulas.
BR9306580A (pt) Xilanase molécula de dna isolda ou recombinada codificando umaxilanase sequência de dna célula hospedeira uso de uma xilanase e molécula de dna isolada ou recombinante
EP0237045A3 (en) Dna encoding flagellin and vector having the same
IE822488L (en) Cloning vectors for use in streptomyces and related¹organisms
AU4401689A (en) Recombinant dna coding for bacillus thuringiensis endotoxin
IL88171A0 (en) Recombinant dna expression vectors and dna compounds that encode isopenicillin n synthetease from streptomyces lipmanii
IL103766A0 (en) Preparation of daunorubicin
GR1002049B (en) Isolation and characterization of genes resistant to anthracycline antibiotics
EP0472399A3 (en) Hla-dr antigen gene, its nucleotide sequence and its use
EP0345546A3 (en) Dna coding for enzyme capable of acylating the 4''-position of macrolide antibiotics
IL70662A (en) Recombinant dna expression vectors useful in bacillus and e.coli host cells
AU8091794A (en) Dna sequence encoding a polypeptide with anti-tumor properties
ZA891463B (en) Bacillus thuringiensis genes,toxins and methods
WO1999055829A3 (en) Process for preparing doxorubicin
AU8957091A (en) Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
AU5253898A (en) Recombinant by55 and nucleic acids encoding same
TW342413B (en) Novel toxins isolated from Bracon Hebetor
AU3727785A (en) Vector based on pfj258 and dna segments which codes antibiotic resistance for use in streptomyces and e. coli
ATE125868T1 (de) Neue tylosin-biosynthese-gene.
AU2404797A (en) Novel proteins c16 and c16n or genes encoding the same
EP1433843A3 (en) Novel xylanases, genes encoding them, and uses thereof
HU9802458D0 (en) Dna fragment encoding a polypeptide with hydrolase activity, plasmid containing same, and microorganism transformed with the plasmid

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees